Accordingly, BIN1 reduces the β-secretase-mediated processing of APP exclusively in the neurons in a RIN3-dependent manner [102], providing interesting mechanistic insights on how these two AD-associated endocytic molecules controlling the Aβ production can mediate in vivo the anti-amyloidogenic effect of 12A12mAb [159]. Here, BIN1 is linked to Alzheimer disease.